ライフサイエンスコーパス: seroconvert

1 These ferrets did not shed the virus or seroconvert.

2 al challenges with SIV(mac251) and failed to seroconvert.

3 ers in sera than those whose infants did not seroconvert.

4 project who were exposed to HIV but did not seroconvert.

5 ate (CA2), even though these animals did not seroconvert.

6 on of HPV-16 DNA than were women who did not seroconvert.

7 e immunity, but not all infected individuals seroconvert.

8 tissue inflammatory response, and failed to seroconvert.

9 in serum and IC were generally low, and 65% seroconverted.

10 r H+ pigs (66%) than non-A+ or H+ pigs (25%) seroconverted.

11 Overall, 64% of patients seroconverted.

12 oronasally and i.v. inoculated chickens had seroconverted.

13 l exposure group shed the virus in feces and seroconverted.

14 immunization and for 52 weeks for those who seroconverted.

15 of 15 initially negative children, 5 (33.3%) seroconverted.

16 e from Europe, Australia, and Canada who had seroconverted.

17 ronegative for measles; of these, 44 (93.6%) seroconverted.

18 t exhibited mild clinical symptoms, but they seroconverted.

19 er, some women with persistent HPV DNA never seroconverted.

20 osures and remained asymptomatic, and no one seroconverted.

21 patients with HBV DNA levels >104 genomes/mL seroconverted.

22 ter 2 injections, all subjects in all groups seroconverted.

23 ds, and 50 to 60% of 3-, 4-, and 5-year-olds seroconverted.

24 ll horses at various time points; two horses seroconverted.

25 s and Swiss Webster mice inoculated with CA9 seroconverted.

26 For chimera 3, none of 9 subjects seroconverted.

27 5 (20%) of 25 initially seronegative persons seroconverted.

28 and 67.1% of women with incident infections seroconverted.

29 lthough the virus replicated and the animals seroconverted.

30 235 (12%) individuals seroconverted.

31 and CD86 on B cells was high in patients who seroconverted.

32 en if either they or their male partners HIV seroconverted.

33 d more than one follow-up test and 238 (17%) seroconverted.

34 nd three of 41 placebo recipients (7%, 2-20) seroconverted.

35 inical efficacy equivalent to the proportion seroconverting.

36 One transfusion recipient seroconverted (0.08% [1/1259]), but this patient did not

37 tients who did not receive transfusions also seroconverted (0.18% [1/556]).

38 Of 253 HIV-negative participants, 2 seroconverted (0.29/100 person-years at risk [pyar]); of

39 20 of 193 (10%) infants in the latter group seroconverted 1 week after mOPV2 challenge, resulting in

40 For chimera 4, 7 subjects seroconverted (1 received 10 PFU, 3 received 100 PFU, an

41 For chimera 2, 3 subjects seroconverted (1 received 100 PFU, and 2 received 1000 P

42 Thirty-six (15%) seroconverted (10%-12%/year).

43 Most ANDV-infected deer mice had seroconverted 14 days after inoculation, but none of the

44 dition, 80% (8/10; phase II) of infected RMs seroconverted 14 to 21 days postchallenge.

45 -years in the control group 158 participants seroconverted (31.78 per 100 person-years; 26.83-36.74).

46 One full dose of intramuscular IPV seroconverted 33%, 41%, and 47% of infants against serot

47 less of OPV formulation, were less likely to seroconvert (47%; 95% confidence interval, 39%-54%) than

48 patients with Kaposi's sarcoma (52 percent) seroconverted 6 to 75 months before the clinical appeara

49 1, 2, and 3 on average, whereas 2 full doses seroconverted 79%, 80%, and 90%, respectively.

50 rted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 cop

51 t year were 5.1 times as likely as others to seroconvert (95% CI 1.9-13.7).

52 had sex with men were 8.8 times as likely to seroconvert (95% CI 3.7-20.5) as heterosexual men.

53 histolytica infections, as 15.3% of controls seroconverted after 12 months of follow-up.

54 es at 0, 4, and 12-15-months, and almost all seroconverted after 2 doses given 8-11 months apart.

55 s who were HAV seronegative at baseline, 97% seroconverted after 2 vaccine doses, and 47% had low ant

56 cytomegalovirus (CMV); 6 (5 female, 1 male) seroconverted after a median of 7.5 months.

57 higher percentage of healthy subjects (93%) seroconverted after a single dose of the hepatitis A vac

58 noculated with tetravalent YF/DEN1-4 vaccine seroconverted after a single dose.

59 Mice that had seroconverted after exposure to P. carinii-infected SCID

60 bsequent dried blood spot tests, of whom 503 seroconverted after follow-up of 22 891 person-years.

61 ho were type-2 seronegative, 42 (100%) of 42 seroconverted after GlaxoSmithKline intramuscular IPV, a

62 The patient seroconverted after immune reconstitution during receipt

63 ) of 97 infants who were type-3 seronegative seroconverted after intramuscular IPV, and 21 (36%) of 4

64 rt, we identified one individual (LSC63) who seroconverted after over 2 years of repeated unprotected

65 of the children seronegative at age 9 months seroconverted after receiving two doses of measles vacci

66 However, 18 of 19 children seroconverted after revaccination.

67 Similarly, mothers whose infants' IgA seroconverted after RV1 had significantly lower pre-dose

68 nza-like symptoms and lung lesions, and they seroconverted after virus inoculation.

69 All participants seroconverted against all 4 serotypes after receiving 3

70 5,5,5,5) or a low-dose (3,3,3,3) formulation seroconverted against all four DEN virus serotypes.

71 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared wi

72 h higher diarrhea scores were more likely to seroconvert and developed higher intestinal IgA and IgG

73 ing 30% of the transplant recipients did not seroconvert and were asymptomatic.

74 who were HIV-negative, 536 were observed to seroconvert and were followed up for up to 13 years.

75 -FIV activity during acute infection did not seroconvert and yielded no evidence of FIV infection at

76 The percentages of participants who seroconverted and achieved seroprotection were similar b

77 All vaccinated animals were seroconverted and developed neutralizing antibody respon

78 ss I loci was performed for 850 patients who seroconverted and had known dates of HIV-1 infection.

79 ct control pigs shed the virus in feces; two seroconverted and one became viremic.

80 Comparisons were made between children who seroconverted and progressed to type 1 diabetes (progres

81 ted; of the 15 whose serostatus changed, all seroconverted and were significantly younger than those

82 riments did not show clinical signs, did not seroconvert, and did not have detectable M. agassizii by

83 Uninoculated cage mates failed to seroconvert, and viral RNA was not detected in their tis

84 percent of the HuNoV-HS66-inoculated calves seroconverted, and 100% coproconverted with immunoglobul

85 men had acute HIV infection at enrollment, 4 seroconverted, and 2 were identified as recently infecte

86 Of 148 healthy child vaccinees, 113 (76%) seroconverted, and 24% had no detectable VZV FAMA antibo

87 All of the experimentally infected tortoises seroconverted, and levels of antibody were statistically

88 cattle in both treatment and contact groups seroconverted, and virus was detected in their respirato

89 These effects counterbalance, and women who seroconverted at 24-30 weeks of gestation carried the hi

90 The inoculated turkeys seroconverted at 4 to 8 wpi.

91 ens inoculated with the 10(-2) dilution also seroconverted at 8 wpi.

92 [5-21] at 10 years among those patients who seroconverted at ages < 15, 15-34, 35-54, and > or = 55)

93 Both animals seroconverted at least 6 months after the interruption o

94 y-infused animal until week 12; both animals seroconverted at week 14.

95 le genes of the gtrA,B, gtr(type) cluster in seroconverting bacteriophages.

96 f the AIDS-KS patients who were examined IgG-seroconverted before KS development, and antibody levels

97 An additional 22% seroconverted before or after transplant, and were asymp

98 group and 157 of 1 184 in the placebo group seroconverted between months 13 and 25, giving a vaccine

99 e-control study comparing 58 respondents who seroconverted between visits with 1134 controls who rema

100 eived EBV+ grafts; 8 others with EBV+ grafts seroconverted but did not become symptomatic.

101 ificantly lower than in men who subsequently seroconverted but had no evidence of early infection.

102 ccines) developed subclinical infections and seroconverted but were only partially protected against

103 d PCR amplification, whereas several rabbits seroconverted but were PCR and culture negative.

104 H. hepaticus-infected mice seroconverted by 2 weeks and maintained ELISA reactivity

105 and groups 3 and 4 became virus positive and seroconverted by 3 to 5 weeks postinoculation.

106 Of these, 676 (98.8%) seroconverted by age 16 months.

107 On the basis of an aoHGE lysate ELISA, mice seroconverted by day 10 after inoculation.

108 tibody reactivity, and only six case mothers seroconverted by either assay.

109 s: one, four, four, and one person of eleven seroconverted by haemagglutination inhibition, microneut

110 We found that 13 of 22 D(+)R(-) LTRs (59.1%) seroconverted (CMV IgG Ab(+)).

111 he booster dose, 98% of compensated patients seroconverted compared with 65.7% with decompensated dis

112 The group of 536 who seroconverted constituted the study population.

113 Twenty of these specimens were from recently seroconverted drug-naive persons, and 30 were from patie

114 first pandemic wave, 12.2% of the population seroconverted due to infection and the seroprevalence af

115 and the proportion of those susceptible that seroconverted due to infection, from a single sample of

116 icate that 30% of children and 33% of adults seroconvert during interferon-alpha treatment and follow

117 we attempted to classify TDR among women who seroconverted during 2008-2010 and who were identified f

118 Four of 17 initially seronegative partners seroconverted during 23 person-years of observation.

119 ined asymptomatic, and none of these animals seroconverted during an extended quarantine period.

120 y, 3371 were HIV positive on entry, and 2737 seroconverted during follow-up (1962 had a seroconversio

121 413 initially HIV-uninfected participants, 8 seroconverted during follow-up.

122 on the transmission bottleneck in women who seroconverted during the CAPRISA 004 microbicide trial.

123 Eight children seroconverted during the outbreak without revaccination

124 The women who seroconverted during the trial reported a significant in

125 0) of the 28 controls with follow-up samples seroconverted (exact p value = 0.0008).

126 ent HPV DNA was associated with a failure to seroconvert following incident HPV infection; however, s

127 Patients were more likely to seroconvert for a cross-reactive antigen if they serocon

128 valent or serotype G1-G4 tetravalent vaccine seroconverted for at least one of the six antibodies (85

129 erson-years of follow-up [PYFU], 16 patients seroconverted for HDV, with an overall incidence rate of

130 ected every 2-7 days from 15 individuals who seroconverted for HIV-1 infection in 1994-2000.

131 dent HPV infections, 59.5%, 54.1%, and 68.8% seroconverted for HPV-16, -18, or -6, respectively, with

132 convert for a cross-reactive antigen if they seroconverted for the specific vaccine antigen.

133 tive sex partners of HTLV-I and -II carriers seroconverted, for an incidence rate (IR) of 0.6 transmi

134 hepatitis B e antigen-positive patients who seroconverted from hepatitis B e antigen to hepatitis B

135 15 875 individuals seroconverting from 1979 to 2008 fulfilled the inclusion

136 children, 73% older children and 72% adults seroconverted (>/=4 fold titer rise) after the 1(st) OCV

137 Interestingly, patients who seroconverted had significantly lower serum levels of G-

138 of mice with soluble protein (sTat), and in seroconverting humans, and propose that Tat-induced supp

139 h sera obtained from four pregnant women who seroconverted (IgG and IgM antibodies) during pregnancy

140 Dogs have been demonstrated to seroconvert in response to diverse IAVs, and naturally o

141 ll product were significantly more likely to seroconvert in response to the influenza vaccine (P = .0

142 After MMR3, 82% (14/17) and 91% (10/11) seroconverted in 7-10 days and 2-3 months, respectively.

143 homologous to the outbreak strain, but most seroconverted in response to other genetically distinct

144 nfection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide t

145 of the 415 initially HIV-1-negative partners seroconverted (incidence, 11.8 per 100 person-years).

146 0 person-years of follow-up, 29 participants seroconverted (incidence: 10.0/100 person-years).

147 +)IFN-gamma(+) T cells in the PBMC of 90% of seroconverted individuals following primary infection by

148 -negative OFOQ results occurred in 80 of 287 seroconverting individuals.

149 milar sequences were also determined from 18 seroconverting injection drug users in Baltimore.

150 ion of HIV-1 env sequences was studied in 15 seroconverting injection drug users selected for differe

151 eripheral blood mononuclear cells of the EBV-seroconverted kidney recipient 20 months after lymphoma

152 y day 57, 52 (92%) of vaccine recipients had seroconverted (microneutralisation titre >/=1:10), with

153 titres, the percentage of participants that seroconverted, microneutralisation titres, and the numbe

154 The number of infants who seroconverted or had a four-fold rise in titres was also

155 who had >/=1 additional HCV Ab test, 23 (6%) seroconverted over 1408 person-years, for an annualized

156 respiratory disease than those that did not seroconvert (P < 0.001), and dogs with preexisting antib

157 cell losses (P < or = 0.013), and failure to seroconvert (P < or = 0.005) were correlated statistical

158 evels significantly higher than in the never-seroconverted (P = 0.02) and the pre-seroconverted (P =

159 e never-seroconverted (P = 0.02) and the pre-seroconverted (P = 0.03) children, but then declined to

160 iable models, early set-point viral loads in seroconverting partners were a complex function of (i) t

161 all pairs near the time of transmission, and seroconverting partners were followed for a median of 84

162 Of 64 seroconverted patients followed for at least 30 months o

163 Eighty-two of the 142 seroconverted patients have stopped producing antibody t

164 Among seroconverted patients, after 30-36 mo of treatment, sev

165 high proportion of SRA positivity among EIA-seroconverting patients (8/11 [73%]) suggests that patie

166 ng the gp120 proteins of isolates from early seroconverting patients.

167 The majority (75%) of the seroconverted population had no detectable levels of cir

168 Thirteen infected dogs (group A), which seroconverted rapidly (maximum titers within 50 to 90 da

169 R(+) CD8(+) T cells was greater in those who seroconverted, relative to the frequency in those who re

170 in addition to bOPV, 80% and 100% of infants seroconverted, respectively, and the vaccination induced

171 101 (3%), 41 (33%), and 25 (1%) of patients seroconverted, respectively.

172 receptive anal intercourse without a condom seroconverted significantly more often than those report

173 gh sex between men, aged 30-39 years, having seroconverted since 2006, enrolled within 6 months of se

174 ogs with mild or no clinical signs (group B) seroconverted slowly (peak titers after 90 days), and on

175 Few of the seroconverting subjects reported hepatitis-like illness.

176 rtner who injected drugs were less likely to seroconvert than other women (0.32 [0.11-0.92]).

177 l (to <104 genomes/mL) appear more likely to seroconvert than patients who do not achieve this level

178 en younger than 40 years were more likely to seroconvert than those 40 years or older (2.8 [1.05-7.6]

179 among HIV-1-positive subjects whose partners seroconverted than among those whose partners did not se

180 For chimera 1, 1 of 9 seroconverted (the seroconverter received 100 PFU).

181 Moreover, treatment responders did not seroconvert to islet cell antibodies.

182 ernatants from the same cell line, failed to seroconvert to VCA and did not develop disease.

183 e, 47 (62%) of 76 participants given vaccine seroconverted to all four serotypes and 73 (96%) partici

184 h1 cytokines in patients who cleared HBV and seroconverted to anti- hepatitis B e, unlike the 23 nonr

185 Five seroconverted to anti-HBs (responders).

186 he Transfusion-Transmitted Viruses Study who seroconverted to anti-HCV after receiving infected blood

187 All HEV-inoculated pigs seroconverted to anti-HEV immunoglobulin G.

188 he virus in feces; two pigs were viremic and seroconverted to anti-HEV.

189 However, fewer than one-third seroconverted to any prototype G1-G4 human rotavirus.

190 Five of ten animals seroconverted to C. trachomatis.

191 t by day 62 postvaccination, 100% of animals seroconverted to DENV-1, -2, -3, and -4.

192 icipants, 39% (420/1077) and 53% (1595/2997) seroconverted to DENV-3 and DENV-4, respectively.

193 L/129 IL-10(-/-) mice were colonized and had seroconverted to H. saguini antigen with a significant T

194 ependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100

195 mean follow-up time, 39 months), 69 (33.2%) seroconverted to HCV.

196 (elevated liver enzyme levels in serum) and seroconverted to HEV, those receiving an inoculum incuba

197 in 10 persons with chronic HCV infection who seroconverted to HIV and, over the next 3 years, had slo

198 Overall, 277 persons seroconverted to HIV during 8,826.45 person-years of fol

199 case-control study of 116 case subjects who seroconverted to HIV during follow-up and 342 control su

200 to HIV-1 were compared with 184 men who had seroconverted to HIV positive and had lower risk.

201 tions (23.6/100 person-years), and 265 women seroconverted to HIV-1 (7.7/100 person-years).

202 A total of 85 men seroconverted to HIV-1 over the period of observation, g

203 45 women seroconverted to HIV.

204 after the third QHPV dose, 67% of vaccinees seroconverted to HPV31, an HPV16-related genotype not in

205 A total of 131 participants seroconverted to HSV-2 (79 of 1041 assigned to tenofovir

206 children vaccinated at 15 months of age, 98% seroconverted to measles, compared with 95% of those vac

207 with GAS pharyngitis and invasive infections seroconverted to most of the 16 recombinant proteins, wh

208 In the first outbreak, only three of nine seroconverted to NV, which was likely due to late collec

209 f the 106 eligible pairs tested, 21 patients seroconverted to one or more antigens.

210 Most animals seroconverted to only a subset of these fimbrial antigen

211 Group 2 and 5 pigs all seroconverted to PCV1 antibody.

212 tvaccination (DPV), the majority of pigs had seroconverted to PCV2 capsid antibody.

213 Inoculated rabbits seroconverted to positivity for antibodies against HTLV-

214 canis, and 25 to Bartonella vinsonii, and 22 seroconverted to Rickettsia rickettsii antigens.

215 Five of the six volunteers seroconverted to S. enterica serovar Typhimurium antigen

216 Three of six (three of five who seroconverted to Salmonella) had immune responses in the

217 In the azithromycin group, 175 (50%) seroconverted to serotype-3 poliovirus compared with 192

218 al signs and symptoms of GAS pharyngitis and seroconverted to several GAS extracellular proteins.

219 ive infections and pharyngitis caused by GAS seroconverted to Shp, indicating that Shp was produced i

220 and patients with streptococcal pharyngitis seroconverted to Sse, indicating that Sse was produced i

221 Each monkey immunized with TV-1 and TV-3 seroconverted to the four DEN components by day 28 with

222 , and 16% of initially seronegative subjects seroconverted to the H3N2, B, and H1N1 antigens, respect

223 iitis) caused by six distinct M types of GAS seroconverted to the streptococcal cysteine protease.

224 dual patients demonstrated that the majority seroconverted to these proteins, confirming results with

225 all four serotypes and 73 (96%) participants seroconverted to three or more dengue viruses.

226 ants (100%, 98.0-100; p<0.0001 vs bOPV-only) seroconverted to type 2.

227 apsid antigen (VCA) of EBV; all animals that seroconverted to VCA developed malignant lymphoma within

228 For assay development: 104 persons seroconverting to HIV-1 comprising 38 plasma donors, 18

229 The proportions of children seroconverting to type 2 poliovirus in the IPV-bOPV-bOPV

230 h Procleix HCV reactive/seronegative results seroconverted upon follow-up and were confirmed as Procl

231 Women who seroconverted were 5.7 times (95% confidence interval =

232 iduals enrolled in the iPrEx trial who later seroconverted were matched with 480 samples from enrolle

233 ir resistance remains a concern in women who seroconvert while using the gel despite the lack of plas

234 Dogs that were seronegative on entry but seroconverted while in the kennel were 4 times more like

235 Only 9% of subjects who received LAIV seroconverted, while 33% of patients developed at least

236 shed virus nasally or rectally, but all pigs seroconverted with antibodies to HRV.

237 rrhea and fecal and nasal virus shedding and seroconverted with serum and intestinal HRV antibodies.

238 unodeficiency virus type 1 (HIV-1) typically seroconvert within weeks of primary infection.

239 CR positive within 3 weeks postinfection and seroconverted without exhibiting clinical disease; howev

240 In contrast, almost all of those who seroconverted without illness (97%) experienced primary

241 Among seroconverting Zambian (n = 240) and Rwandan (n = 64) pa